M. Sánchez

Four-Year Treatment Outcomes of Adult Patients Enrolled in Mozambique's Rapidly Expanding Antiretroviral Therapy Program

L. Nelson, R. Shiraishi, T. Ellerbrock, 2011, PloS one.

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

B. Clotet, M. Odriozola, J. Olalla, 2017, The Journal of antimicrobial chemotherapy.

Incidence and Determinants of Tuberculosis among Adults Initiating Antiretroviral Therapy – Mozambique, 2004–2008

L. Nelson, R. Shiraishi, T. Ellerbrock, 2013, PloS one.

Inadequate therapy and antibiotic resistance. Risk factors for mortality in the intensive care unit.

J. Calva, J. Sifuentes-Osornio, M. Zaidi, 2002, Archives of medical research.